Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preventing radiation induced xerostomia.

Michael I Koukourakis1, Vassilios Danielidis

  • 1Department of Radiotherapy - Oncology, Medical School, Democritus University of Thrace, Tumour & Angiogenesis Research Group, P.O. Box 12, Alexandroupolis 68100, Greece. targ@her.forthnet.gr

Cancer Treatment Reviews
|November 1, 2005
PubMed
Summary

Radiotherapy for head and neck cancer often causes dry mouth (xerostomia). This review explores new technologies and drugs like amifostine to reduce this common side effect and improve patient quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lactate Dehydrogenase-5 and Tumor-Infiltrating Lymphocytes in Prostate Cancer Patients Undergoing Radical Hypofractionated Radiotherapy.

Cancers·2026
Same author

Metabolism and Immunity-Adapted Radiotherapy (M.I.A.R): A Conceptual Framework for Overcoming the Therapeutic Plateau in Clinical Radiotherapy.

Current oncology (Toronto, Ont.)·2026
Same author

Pseudoprogression of a head and neck cutaneous squamous cell carcinoma treated with anti-PD-1 immunotherapy: a case report and review of the literature.

Chemotherapy·2026
Same author

MRI-Derived Biomarkers and Radiomic Signatures for Early, Dose-Dependent Evaluation of Prostate Cancer Radiotherapy: An Exploratory Study.

Journal of imaging·2026
Same author

Phytochemicals with epigenetic properties and their role in melanoma therapy.

International review of cell and molecular biology·2026
Same author

18F-FDG PET-CT- vs. CT-Based Radiotherapy Treatment Planning for Head and Neck Cancer.

Life (Basel, Switzerland)·2026

Area of Science:

  • Oncology
  • Radiation Oncology
  • Head and Neck Cancer Treatment

Background:

  • Radiation-induced xerostomia is a common and debilitating side effect of radiotherapy for head and neck cancer.
  • Persistent dry mouth significantly impairs the quality of life for over 70% of treated patients.
  • While pilocarpine can help acute symptoms, chronic xerostomia remains a significant challenge.

Purpose of the Study:

  • To review current technological advancements in radiotherapy for head and neck cancer.
  • To discuss pharmacological strategies for preventing and reducing radiation-induced xerostomia.
  • To explore methods for mitigating both acute and late-onset dry mouth in patients.

Main Methods:

  • Review of current literature on radiotherapy techniques.

Related Experiment Videos

  • Discussion of technological developments such as conformal RT and intensity-modulated RT.
  • Analysis of pharmacological interventions, including amifostine.

    • Main Results:

    • Conformal and intensity-modulated RT offer potential for reducing parotid gland radiation exposure.
    • Amifostine has been investigated as a radioprotective agent to mitigate xerostomia.
    • Despite advancements, chronic xerostomia remains prevalent in head and neck cancer patients.

    Conclusions:

    • Technological innovations in RT aim to spare salivary glands and reduce xerostomia.
    • Pharmacological agents like amifostine show promise in managing radiation-induced dry mouth.
    • Further research and implementation of these strategies are crucial for improving patient outcomes and quality of life.